Lenalidomide-4-aminomethyl is a specialized chemical intermediate primarily used in medicinal chemistry research for the development of novel therapeutic agents, especially in oncology. It facilitates the synthesis of complex molecules for targeted cancer treatments by allowing structural modifications that improve drug efficacy and specificity, such as inhibiting tumor growth or inducing apoptosis. This compound is also investigated in immunomodulatory applications to enhance immune recognition of cancer cells and in combination therapies to optimize existing treatments.